NCCN Collaborative Projects in Advanced Ovarian Cancer
Can Ovarian RADS MRI Identify Ovarian Cancer in Indeterminate Masses?
FDA Accepts sNDA for Niraparib in First-Line Maintenance Treatment of Ovarian Cancer
Fox Chase Researchers Receive Grant to Study High-Grade Serous Ovarian Cancer
Characterization of Exosomes From Ovarian Cancer and Ovarian Epithelial Cells
Genetic Change May Distinguish Rare Benign Ovarian Tumors From Cancerous Tumors
Cyclophilin A: Potential Therapeutic Target in Serous Ovarian Cancer?
Can Cervical Scrapings From Pap Tests Detect Ovarian Cancer?
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Ovarian Cancer
Consensus or Controversy: Management of initial relapse of ovarian cancer — Eight investigators weigh in on their current approach based on genomic profiling
Oncology Grand Rounds: PARP Inhibitors in Ovarian Cancer
Cases from the Community: Clinical Investigators Provide Their Perspectives on Emerging Research and Actual Patients with Ovarian Cancer
University of Nebraska
Fox Chase Cancer Center
Yale Cancer Center
Siteman Cancer Center
Foundation for Women's Cancer
Ovarian Cancer Research Fund Alliance
Ovations for the Cure of Ovarian Cancer
Rivkin Center for Ovarian Cancer